Institutional investors hold a majority ownership of MYL through the 88.30% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2013, these large investors purchased a net $6.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 6.2 Million shares of Mylan Inc
FIL INVESTMENTS INTERNATIONAL Bought 2.7 Million shares of Mylan Inc
BMO ASSET MANAGEMENT, INC. Bought 2.7 Million shares of Mylan Inc